XOMAP FY 2018 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-89.9% YoY

Gross Profit

$4M68.3% margin

Operating Income

-$17M-318.1% margin

Net Income

-$13M-251.8% margin

EPS (Diluted)

$-1.18

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$28M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$64M

Total Liabilities

$45M

Stockholders' Equity

$19M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$53M	-89.9%
Gross Profit	$4M	$45M	-91.9%
Operating Income	-$17M	$17M	-199.0%
Net Income	-$13M	$15M	-191.4%